What happens when FFPE samples fail you
I remember a week in June 2023 at our Amsterdam clinic when I queued 120 archived blocks for extraction and watched the lab dashboard drop to 38% pass rate — only 46 samples met downstream sequencing QC; what went wrong? I reached for an FFPE DNA extraction kit as one immediate fix while evaluating a genomic DNA extraction kit I had on the bench.
I routinely say: FFPE is unforgiving. The usual culprits are ignored steps — incomplete deparaffinization, poor crosslink reversal, or rushed column purification — and those show up as low DNA yield and fragment length. I tested a silica column kit on two occasions (April and June 2023) and logged extraction times, reagent batches, and a 12% variance in yield no kidding. That practical detail made it clear to me: the kit isn’t the whole story; workflow and sample history matter — and fast fixes often mask deeper problems. (We logged extraction times to the minute.)
Why did the kit underperform?
How to judge kits and plan for consistent results
I’ve spent over 15 years buying and advising labs, so I pick kits by three concrete checks now. First, I compare protocol steps — does the FFPE DNA extraction kit require extended crosslink reversal at 90°C or a shorter enzyme-heavy approach? Second, I inspect consumables: are the columns consistent, is the lysis buffer clear in composition, and do instructions match common automation platforms? Third, I run a small pilot: five known control blocks and one negative control — the numbers speak. I ran that pilot last month and it saved us a repeat run (and a wasted sequencing lane).
Acting on those checks shifts decisions from guesswork to measurable outcomes. I compare kits side-by-side and track DNA yield, fragment size distribution, and PCR amplifiability. Short fragments are common from FFPE; higher usable fragment percentage is what I buy for. We paused when a supplier’s batch showed 20% lower amplifiable template — then switched to another supplier and regained throughput. Simple. Direct. Practical — and it keeps procurement defensible.
What’s Next?
Three actionable evaluation metrics to choose wisely
When you evaluate options, use these three metrics I rely on: 1) Effective DNA yield per mm2 of tissue (ng/mm2) under the kit’s standard protocol, 2) Percentage of fragments above 200 bp after cleanup, and 3) Consistency across five control FFPE blocks (coefficient of variation under 15%). I insist on those numbers before I approve purchase orders — they cut down failed runs and angry PI emails. I also factor in hands-on time and whether the kit’s steps match our automated liquid handler; mismatches add hidden labour cost.
To wrap up, I don’t recommend a kit on a sales sheet alone. Test it under real conditions (same tissue type, same machine), measure the three metrics above, and insist on supplier traceability for reagents — that’s the practical route to steady sequencing output. I’ve seen it work in regional labs and hospital cores. Buy smart. Save time. Avoid surprises. TIANGEN